需要订阅 JoVE 才能查看此. 登录或开始免费试用。

本文内容

  • 摘要
  • 摘要
  • 引言
  • 研究方案
  • 结果
  • 讨论
  • 披露声明
  • 致谢
  • 材料
  • 参考文献
  • 转载和许可

摘要

Here, we present a method to differentiate and expand human iPSC-derived chimeric antigen receptor (CAR)-expressing natural killer cells with improved killing against various malignancies. This protocol demonstrates the differentiation and expansion of natural killer (NK) optimized iPSC-derived CAR-NK cells and the measurement of antitumor activity against various tumor cell lines.

摘要

Natural killer (NK) cells are innate immune cells that play a crucial role in the body's defense against tumors and viral infections. The generation of human induced pluripotent stem cell (iPSC)-derived chimeric antigen receptor (CAR) expressing NK cells has emerged as a promising avenue for "off the shelf" cancer immunotherapy. Here, we utilized an NK cell-optimized CAR construct that includes the transmembrane domain of NKG2D, the 2B4 co-stimulatory domain, and the CD3ζ signaling domain, which has been demonstrated to stimulate robust antigen-specific NK cell-mediated antitumor activity. The use of iPSCs for CAR NK cell generation offers several advantages, including homogenous CAR expression, scalability, reproducibility, and the potential for clinical application. This detailed step-by-step protocol from cell engineering to differentiation enables the generation of NK cell-optimized iPSC-derived CAR-expressing NK cells, providing a standardized and targeted cancer immunotherapy with improved antitumor activity and highlighting their potential as a promising treatment option for various malignancies.

引言

NK cells, a type of lymphocyte within the innate immune system, are pivotal in the early defense against tumors and virally infected cells1,2,3. Unlike T cells, NK cells do not require antigen presentation via major histocompatibility complex (MHC) molecules. Instead, NK cells have a repertoire of activating and inhibitory receptors that regulate their activity3. NK cell-mediated cytotoxic activity utilizes various mechanisms, including the release of perforin and granzymes, engagement of death receptors, and the production of pro-inflammatory cytokine....

研究方案

1. Feeder-free culture method of human iPSCs

NOTE: Thaw the frozen undifferentiated human iPSCs and culture them with the use of mTeSR 1-plus on Matrigel (henceforth referred to as basement membrane matrix [BMM]) pre-coated plates, as previously described23,34. It is very important to make sure the iPSCs are not differentiated before and after engineering. Freshly thawed iPSCs should be cultured for about 2-3 passages to exhibit pluripotency morphology consistent with the human pluripotent stem cells. The following instructions are used for passaging cells from one we....

结果

Schematic diagram of anti-GPC3-CAR iPSC derived NK cells differentiation and expansion
The schematic diagram illustrates the in vitro differentiation of anti-GPC3-CAR engineered NK cells derived from human induced pluripotent stem cells (iPSCs) and a schematic representation of piggyBac vector carrying GPC3 CAR construct. Initially, unmodified iPSCs are transfected with a piggyBac vector encoding the GPC3 CAR (chimeric antigen receptor). Following transfection, these GPC3 CAR-expressing iP.......

讨论

This protocol outlines a standardized and reproducible approach for generating CAR-expressing, iPSC-derived NK cells from a consistent cell source aimed at facilitating targeted "off-the-shelf" cancer immunotherapy. Multiple preclinical and clinical studies have shown the efficacy of adoptive NK cell-based immunotherapy in treating cancers while minimizing toxicities, like graft versus host diseases (GvHD) or cytokine-release syndrome (CRS)23,42,

披露声明

DSK is a co-founder and advisor to Shoreline Biosciences and has an equity interest in the company. DSK also consults for Therabest and RedC Bio for which he receives income and/or equity. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.

致谢

We thank all Kaufman lab members for their support, scientific insights and discussions. These studies were supported by the NIH/NCI grants U01CA217885, P30CA023100 (administrative supplement) and the Sanford Stem Cell Institute at UCSD. JT: writing and revision of manuscript. DSK: reviewed and edited the manuscript.

....

材料

NameCompanyCatalog NumberComments
aAPC Dean A. Lee lab N/A
a-MEM culture medium Fisher Scientific Cat#12634
APC anti-DYKDDDDK (FLAG Tag)BD Biosciences Cat#637308
APC-anti-human TRA-1-81 ThermoFisher17-8883-42 
APC-CD16BD Biosciences Cat#302015
APC-CD43 BD BiosciencesCat# 560198 
APC-CD45 BD BiosciencesCat# 555485 
APC-GPC3BD Biosciences Cat#DB100B
APC-NKG2D BD Biosciences Cat# 558071 
CellEvent Caspase-3/7 Green Detection Reagent Thermo fisher Cat#C10423
CellTrace Violet Cell Proliferation Kit Thermo fisher Cat#C34571Cell tracing fluorescent dye 
CryoStor solution Stem Cell Technologieshttps://www.stemcell.com/products/cryostor-cs10.htmlCryopreservation medium
CTS NK XpanderGibcoA5019001
CTS NK-Xpander MediumLife TechnologiesCat#A5019001
DMEMGibco11965084
DMEM, high glucose, GlutaMAX Supplement, pyruvateGibco10569010
EasySep Human NK Cell Enrichment Kit StemCell Technologies, Inc. Cat#19055
EthanolamineSigma AldrichE9508
Fetal bovine serum Fisher Scientific Cat# 10437010
FITC-CD94 BD Biosciences Cat#555888
GlutaMAX SupplementGibco35050061
GolgiPlug BD Biosciences Cat#555029
GolgiStop BD Biosciences Cat#554724
Ham's F-12 Nutrient Mix, GlutaMAX SupplementGibco31765035
Horse serum Fisher Scientific Cat#16050130
Human Serum AB Sigma-AldrichCat#BP2525100
Human Stem Cell NucleofectorTM Kit Lonza Cat# VPH-5012
Human: HePG2 cells ATCC Cat#HB-8065
Human: HePG2-td-tomato-luc cells Dan S. Kaufman labN/A
Human: iPS cells Dan S. Kaufman lab N/A
Human: SNU-449 cells ATCCCat#CRL-2234
Human: SNU-449-td-tomato-luc cells Dan S. Kaufman labN/A
IncuCyte Caspase-3/7 Green Apoptosis Assay Essenbioscience Cat#4440
L-Ascorbic acidSigma AldrichA5960
MP Biomedicals Human Serum, Type ABMP BiomedicalsICN2938249
mTeSR plusStemCell Technologies, Inc. 100-0276
NovoExpress software ACEA Biosciences https://www.agilent.com/en/product/research-flow-cytometry/flow-cytometry-software/novocyte-novoexpress-software-1320805
PE/Cy7 anti-human SSEA-4 Antibody Biolegend330420
PE-CD16 BD Biosciences Cat#560995 
PE-CD226BD Biosciences Cat#559789
PE-CD34 BD BiosciencesCat# 555822 
PE-CD45 BD Biosciences Cat# 555483 
PE-CD94 BD Biosciences Cat#555888 
PE-cy7-CD56 BioLegendCat# 318318 
PE-FAS Ligand BD Biosciences Cat#564261 
PE-NKp30BD BiosciencesCat# 558407
PE-NKp44 BD Biosciences Cat#558563 
PE-NKp46BD Biosciences Cat#331908
PE-NKp46 BD Biosciences Cat#557991 
Peripheral blood buffy coat San Diego Blood Bank (https://www. sandiegobloodbank.org/) N/A
PE-TRAIL BD Biosciences Cat#565499 
pKT2-mCAG-IRES-GFP-ZEO Branden Moriarity lab N/A
pMAX-GFP plasmidLonzaN/AGFP positive control 
Prism 9Graphpad Version 9
pSpCas9 GenScriptPX165
RBC Lysis Buffer (10x)BiolegendCat#420301
Recombinant human bFGF basic R&D Systems Cat#4114-TC
Recombinant human BMP-4 PeproTechCat#120-05
Recombinant human FLT-3 Ligand PeproTechCat# 300-19
Recombinant human IL-15 PeproTechCat# 200-15
Recombinant human IL-2 PeproTechCat# 200-02
Recombinant human IL-3 PeproTechCat#200-03
Recombinant human IL-7 PeproTechCat# 200-07
Recombinant Human Nodal ProteinR&D Systems Cat#3218-ND-025
Recombinant human SCF PeproTechCat# 300-07
Recombinant Human TGF-β1PeproTechCat#100-21
Recombinant human VEGF PeproTechCat# 100-20
RPMI1640Gibco11875093
Sodium seleniteSigma Aldrich214485
STEMdiff APEL 2 MediumStemCell Technologies, Inc. 5270EB formation medium
STEMdiff APEL2 Medium StemCell Technologies, Inc. Cat#05270
Super piggyBac Transposase expression vectorSBICat#PB210PA-1
SYTOX AADvanced Dead Cell Stain KitThermoFisher ScientificS10274, S10349Dead cell staining solution kit
β-mercaptoethanolGibco21985023

参考文献

转载和许可

请求许可使用此 JoVE 文章的文本或图形

请求许可

This article has been published

Video Coming Soon

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。